
M. Franco G. Salvoza
Examiner (ID: 17080, Phone: (571)272-4468 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1672, 1648, 1671 |
| Total Applications | 790 |
| Issued Applications | 451 |
| Pending Applications | 119 |
| Abandoned Applications | 243 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19650065
[patent_doc_number] => 12171825
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Vaccine against infectious bronchitis
[patent_app_type] => utility
[patent_app_number] => 17/374399
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8583
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17374399
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/374399 | Vaccine against infectious bronchitis | Jul 12, 2021 | Issued |
Array
(
[id] => 18879510
[patent_doc_number] => 20240002879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => GORILLA ADENOVIRUS NUCLEIC ACID- AND AMINO ACID-SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/003858
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 1436
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003858
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/003858 | GORILLA ADENOVIRUS NUCLEIC ACID- AND AMINO ACID-SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREOF | Jun 30, 2021 | Pending |
Array
(
[id] => 19258007
[patent_doc_number] => 12018050
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => AAVrh.10 variants with host antibody escape capabilities and altered tissue targeting properties
[patent_app_type] => utility
[patent_app_number] => 17/359324
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 37
[patent_no_of_words] => 10574
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17359324
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/359324 | AAVrh.10 variants with host antibody escape capabilities and altered tissue targeting properties | Jun 24, 2021 | Issued |
Array
(
[id] => 19097782
[patent_doc_number] => 20240117010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => BINDING PROTEIN SPECIFIC FOR THE SPIKE PROTEIN OF SEVERE ACUTE RESPIRATORY SYNDROME CORONA VIRUS 2 (SARS-COV-2)
[patent_app_type] => utility
[patent_app_number] => 18/012284
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19788
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18012284
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/012284 | BINDING PROTEIN SPECIFIC FOR THE SPIKE PROTEIN OF SEVERE ACUTE RESPIRATORY SYNDROME CORONA VIRUS 2 (SARS-COV-2) | Jun 22, 2021 | Pending |
Array
(
[id] => 18498509
[patent_doc_number] => 20230221217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => DEVICE AND METHOD FOR CAPTURING AND ANALYZING AIRBORNE ORGANISMS
[patent_app_type] => utility
[patent_app_number] => 18/008701
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008701
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/008701 | DEVICE AND METHOD FOR CAPTURING AND ANALYZING AIRBORNE ORGANISMS | Jun 13, 2021 | Pending |
Array
(
[id] => 18726349
[patent_doc_number] => 20230340626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => A "LINE ELIMINATION" LATERAL FLOW IMMUNOCHROMATOGRAPHIC STRIP AND ITS APPLICATION IN CRISPR NUCLEIC ACID DETECTION
[patent_app_type] => utility
[patent_app_number] => 18/009975
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009975
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009975 | A "LINE ELIMINATION" LATERAL FLOW IMMUNOCHROMATOGRAPHIC STRIP AND ITS APPLICATION IN CRISPR NUCLEIC ACID DETECTION | Jun 9, 2021 | Pending |
Array
(
[id] => 18511380
[patent_doc_number] => 20230227526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => ENGINEERED T CELL RECEPTORS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/001185
[patent_app_country] => US
[patent_app_date] => 2021-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -82
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001185
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/001185 | ENGINEERED T CELL RECEPTORS AND METHODS OF USE | Jun 7, 2021 | Pending |
Array
(
[id] => 18496190
[patent_doc_number] => 20230218745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => MODIFIED ALPHAVIRUS FOR USE AS COVID-19 VACCINE
[patent_app_type] => utility
[patent_app_number] => 18/000772
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000772
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000772 | MODIFIED ALPHAVIRUS FOR USE AS COVID-19 VACCINE | May 27, 2021 | Pending |
Array
(
[id] => 20106987
[patent_doc_number] => 12357685
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => Vaccine composition for preventing rabies, and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 17/333052
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 1248
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17333052
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/333052 | Vaccine composition for preventing rabies, and preparation method thereof | May 27, 2021 | Issued |
Array
(
[id] => 18437472
[patent_doc_number] => 20230184767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => METHODS AND COMPOSITIONS FOR RAPID DIRECT DETECTION AND DIFFERENTIATION OF INFECTIOUS FROM NONINFECTIOUS VIRUS
[patent_app_type] => utility
[patent_app_number] => 17/926474
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926474
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/926474 | METHODS AND COMPOSITIONS FOR RAPID DIRECT DETECTION AND DIFFERENTIATION OF INFECTIOUS FROM NONINFECTIOUS VIRUS | May 18, 2021 | Pending |
Array
(
[id] => 18675087
[patent_doc_number] => 20230312659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => MRNA OR MRNA COMPOSITION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/926444
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926444
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/926444 | MRNA OR MRNA COMPOSITION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | May 13, 2021 | Abandoned |
Array
(
[id] => 18449640
[patent_doc_number] => 20230190916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTING AND TREATING A SARS-COV-2 INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/925179
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925179
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/925179 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING A SARS-COV-2 INFECTION | May 13, 2021 | Pending |
Array
(
[id] => 17097221
[patent_doc_number] => 20210285012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => METHOD OF DETECTING AND/OR IDENTIFYING ADENO-ASSOCIATED VIRUS (AAV) SEQUENCES AND ISOLATING NOVEL SEQUENCES IDENTIFIED THEREBY
[patent_app_type] => utility
[patent_app_number] => 17/319564
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319564
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319564 | METHOD OF DETECTING AND/OR IDENTIFYING ADENO-ASSOCIATED VIRUS (AAV) SEQUENCES AND ISOLATING NOVEL SEQUENCES IDENTIFIED THEREBY | May 12, 2021 | Abandoned |
Array
(
[id] => 18004980
[patent_doc_number] => 20220363746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => METHODS FOR TREATING CORONAVIRUS INFECTION AND RESULTING INFLAMMATION-INDUCED LUNG INJURY
[patent_app_type] => utility
[patent_app_number] => 17/306884
[patent_app_country] => US
[patent_app_date] => 2021-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -84
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17306884
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/306884 | METHODS FOR TREATING CORONAVIRUS INFECTION AND RESULTING INFLAMMATION-INDUCED LUNG INJURY | May 2, 2021 | Pending |
Array
(
[id] => 17022302
[patent_doc_number] => 20210246173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => MUTANT OF ADENO-ASSOCIATED VIRUS (AAV) CAPSID PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/244106
[patent_app_country] => US
[patent_app_date] => 2021-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17244106
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/244106 | MUTANT OF ADENO-ASSOCIATED VIRUS (AAV) CAPSID PROTEIN | Apr 28, 2021 | Abandoned |
Array
(
[id] => 17185560
[patent_doc_number] => 20210332445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => VIRUS DETECTION PIPELINE
[patent_app_type] => utility
[patent_app_number] => 17/238466
[patent_app_country] => US
[patent_app_date] => 2021-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17238466
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/238466 | VIRUS DETECTION PIPELINE | Apr 22, 2021 | Pending |
Array
(
[id] => 18483677
[patent_doc_number] => 20230210979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => ENGINEERING BROADLY REACTIVE CORONAVIRUS VACCINES AND RELATED DESIGNS AND USES
[patent_app_type] => utility
[patent_app_number] => 17/996727
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996727
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996727 | ENGINEERING BROADLY REACTIVE CORONAVIRUS VACCINES AND RELATED DESIGNS AND USES | Apr 19, 2021 | Pending |
Array
(
[id] => 18374457
[patent_doc_number] => 20230149536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => COMPOSITIONS FOR TREATING AND/OR PREVENTING CORONAVIRUS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/919224
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -127
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17919224
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/919224 | COMPOSITIONS FOR TREATING AND/OR PREVENTING CORONAVIRUS INFECTIONS | Apr 18, 2021 | Pending |
Array
(
[id] => 19423828
[patent_doc_number] => 12083219
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Methods and compositions for the preparation of aerosols
[patent_app_type] => utility
[patent_app_number] => 17/233621
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27185
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233621
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/233621 | Methods and compositions for the preparation of aerosols | Apr 18, 2021 | Issued |
Array
(
[id] => 18449643
[patent_doc_number] => 20230190919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => CORONAVIRUS VACCINE COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/996119
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996119
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996119 | CORONAVIRUS VACCINE COMPOSITIONS AND METHODS OF USE | Apr 12, 2021 | Pending |